Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.4B | 2.3B | 2.2B | 2.1B |
Cost of revenue | 1.4B | 1.2B | 1.2B | 1.1B |
Gross profit | 1.1B | 1.2B | 1.1B | 1.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 564.5M | 670.6M | 575.4M | 548.0M |
Operating income | 395.1M | 377.7M | 384M | 374.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 713K | 627K | 930K | 637K |
Other income expense | — | — | — | — |
Pretax income | 430.6M | 406.4M | 410.5M | 401.2M |
Tax provision | 119.1M | 100.9M | 103.0M | 100.6M |
Net income | 311.5M | 305.5M | 307.6M | 300.7M |
Basic EPS | — | 20.1 | 20.3 | 19.8 |
Diluted EPS | — | 20.1 | 20.3 | 19.8 |
Basic average shares | — | 15.2M | 15.2M | 15.2M |
Diluted average shares | — | 15.2M | 15.2M | 15.2M |
EBITDA | 437.9M | 414.2M | 418.2M | 407.4M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |